openPR Logo
Press release

Genetic Testing Market to Reach US$ 28.5 Billion by 2026 | 23andMe, Inc., Abbott, Illumina, Inc, Ambry Genetics

03-09-2020 03:30 PM CET | Health & Medicine

Press release from: Global Market Insights Inc.

Genetic Testing Market

Genetic Testing Market

Based on the research, the size of the overall Genetic Testing Market was recorded at USD 13 billion in the year 2019 and is now projected to surpass around USD 28.5 billion by 2026.

North America genetic testing market will foresee over 10% growth throughout the forecast years. Increasing prevalence of genetic diseases will prove beneficial for the regional growth. Cystic fibrosis, sickle cell anemia, thalassemia and other genetic disorders affect millions of individuals in the U.S. annually that should spur the demand for upgraded genetic tests. Moreover, favorable regulatory scenario for genetic tests will further positively influence the regional growth.

The unprecedented growth pace of genetic testing market is rather evident from 23andMe's recent launch of a grant program as a part of its Genotyping services for the research platform. A significant market contributor globally, through this invention, aims at promoting research studies with intent to increasing the revenue shares in the upcoming years. This trend itself bears a testimony to the fact that the chief market players are opting for strategic moves to strengthen their position in the global genetic testing market share.

A business vertical of high repute, thriving extensively on personalized medicines, genetic testing market as of today stands as one of the outpaced, profitable industry spheres there is. Endorsed by the availability of technologically sound gene diagnosing kits and elevating cognizance regarding the use of personalized medicines, the commercialization potential of genetic testing industry has surged immensely in the past few years.

Get a Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/2490

Top Key Player: 23andMe, Inc., Abbott, Ambry Genetics, BGI, Biocartis Group NV, Bio-Helix Co. Ltd., bioMerieux SA, Blueprint Genetics, Cepheid, Counsyl, Inc., deCODE Genetics, GeneDx, Genomic Health, Inc., Genomictree, Inc., HTG Molecular Diagnostics, Inc., Illumina, Inc
It is prudent to mention that the genetic testing helps in the early detection of rare genetic diseases which provides it the scope for the treatment in the nascent stage.

Concurrently, various industry mammoths are into developing innovative genetic tests that would provide accurate data on the probability of an individual suffering from a specific gene disease via the next gen sequencing techniques.
Speaking of the test type spectrum, carrier testing segment has stood tall during the past few years and is likely to develop at an appreciable pace during 2019-2025. For the records, the carrier testing segment accounted for USD 460 million in 2018. These tests find large scale use among couples to determine the chances of having a child with genetic disorders.

Also, they focus on detecting the probability of a healthy person carrying mutated genes. These factors have prompted healthcare professionals to recommend required treatments for the individuals comprising mutated genes thereby adding an impetus to genetic testing market trends.

Nutrigenomic testing segment, on the other hand, is expected to stand tall in the upcoming years owing to the advanced genomic techniques to help the doctors suggest the dietary plans according to the genetic makeup of the individuals. This would enable the segment to grow at a CAGR of 13 per cent through 2025.

According to GLOBOCAN 2018 estimates, the world recorded over 9.6 million cancer deaths in 2018 out of which nearly 5 to 10 per cent of them were instigated by inherited genetic mutations. This mounting prevalence of vivid malignant diseases would impel the cancer diagnosis segment to amass noticeable gains over the forecast period.

More Insightful Info: https://www.ptcommunity.com/wire/genetic-testing-market-demand-hit-usd-285-bn-2026-global-market-insights-inc

The role of genetic screening tests in the detection of cancer is to let the system identify mutations and functional characterization of the individual's genetic transformations. This early stage detection would propel the industry growth in the near future,
Elaborating further on the geographical trends, North America is projected to emerge out as one of the major pocket revenues for the genetic testing market. Estimates claim that the region in 2018 accounted for 59 per cent of the global business share and is forecast to observe 10 per cent growth through 2025.

Related Reports:
Esoteric Testing Market: https://www.marketwatch.com/press-release/esoteric-testing-market-size-2019-outlook-opportunity-and-demand-analysis-report-by-2025-2019-09-12

U.S. Direct-to-Consumer Genetic Testing Market: https://www.marketwatch.com/press-release/us-dtc-genetic-testing-market-size-2019-application-and-future-forecast-by-2025-2019-11-20

This regional growth is ascribed to the high prevalence of cancer and genetic diseases across the region. Additionally, advent of technologically advanced gene diagnosing kits in tandem with favourable regulatory framework would help augment the industry outlook.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genetic Testing Market to Reach US$ 28.5 Billion by 2026 | 23andMe, Inc., Abbott, Illumina, Inc, Ambry Genetics here

News-ID: 1959816 • Views:

More Releases from Global Market Insights Inc.

Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Included – Dow Dupont Inc., BASF SE, Clariant AG & More
Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Incl …
The agricultural adjuvants market is expected to observe noteworthy growth on account of increasing demand for high-quality crops. Adjuvants commonly act as an additive in pesticides that increase its effectiveness and smoothen its mixing application. The demand for plant protection products in countries like Bangladesh, India, and Vietnam has surged considerably in recent years. Ever-increasing population across developing economies has forced farmers to produce large quantities of high-quality yields. Citing
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - Walmart, Costco Wholesale Corporation, LGM Pharma
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - …
The U.S. minoxidil industry has been impacted by the COVID-19 pandemic in the form of increased stress amid job losses and health issues, creating rising incidences of hair fall and associated problems. The industry is expected to gain commendable proceeds on account of an upsurge in research studies concerned with the effectiveness of minoxidil. Citing one such instance, in January 2021, a study published in the Dermatologic Therapy supported the efficacy
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Trends to 2024 | MFG Chemicals, Huntsman Corporation, and Stepan Company
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Tren …
Owing to these factors, estimates have revealed that the global sulfosuccinate market size will exceed USD 475.7 million in annual estimation by 2024. Increasing adoption of high-performance materials that meet application-specific requirements across various industries, including pharmaceuticals will stimulate the need for sulfosuccinate compounds. The surging disposable incomes of consumers mainly across the developing nations have also fueled their spending capacities on household and personal care. Sulfosuccinates are mainly a mild type
By 2026, Graphene Market will register over 35% CAGR | Applied Nanotech, Inc, an …
The global Graphene Market is slated to gain significant momentum over the forthcoming years, as a result of the growing product consumption in the electronics sector, particularly in developing countries. This high consumption can be attributed to its superior qualities such as high electrical conductivity, durability, and toughness. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/233 Top Key Players in The Market are: Graphenea S.A., Applied Graphene Materials plc, ACS

All 5 Releases


More Releases for Genetic

Genetic Testing Market to Register Growth due to Increasing Prevalence of Geneti …
The prevalence of diseases, including chronic and genetic diseases, is rising at a swift pace. According to the World Health Organization, a genetic disorder named sickle cell anemia is primarily common among people who had ancestors in India, South America, Central America, Sub-Saharan Africa, Mediterranean countries (including Greece, Turkey, and Italy), Cuba, and Saudi Arabia. In addition to this, the high prevalence of chronic diseases, such as cancer, is also
Genetic Testing Market Demand 2018; by Method Molecular Genetic Test/ DNA Test, …
Universal Genetic Testing Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Genetic Testing market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Genetic Testing Market - Global Insights The Global Genetic Testing Market is growing with the rapid
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic
Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic …
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th) President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Susceptibility Testing 1.1 Prologue to Cancer Susceptibility 1.2 Aspects of Cancer Susceptibility Testing Breast Cancer Susceptibility 2.1 Conceptual of Breast Cancer Susceptibility 2.2 Trail of the Inherited Susceptible Genes Hereditary Breast Cancer Genes 3.1 High Penetrant Genes 3.1.1 Breast Cancer Gene1 (BRCA1) 3.1.2 Breast Cancer Gene 2 (BRCA2)
Rising Prevalence of Genetic Disorders Propels Prenatal and New-born Genetic Tes …
Global Prenatal and New-born Genetic Testing Market: Snapshot Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down